Experimental and computational evidence on conformational fluctuations as a source of catalytic defects in genetic diseases

Julian E. Fuchs, Ines G. Munoz, David Timson, Angel L. Pey

Research output: Contribution to journalArticle

Abstract

Theoretical and experimental evidences have shown that protein function, regulation and degradation are intrinsicallylinked to the dynamic and fluctuating nature of protein ensembles. However, the effect of missense mutations on catalytic performance are often interpreted from conformational analyses derived from X-ray crystallography, molecular dynamics and modeling, while effects on conformational fluctuations at the active site as the source of catalytic defects are rarely investigated. Here, we explore the role of conformational fluctuations in the catalytic efficiency of WT and three missense mutations in the UDP-Galactose 4´-epimerase (GALE) protein causing type III galactosemia. Using comprehensive molecular dynamics simulations and small angle X-ray scattering we correlate low NAD+ binding affinity in some mutants with an increased population of non-competent conformations for NAD+ binding. Proteolysis studies combined with thermodynamic calculations reveal that mutations affecting GALE catalytic performance favor larger conformational fluctuations at the N-terminal domain and NAD+ binding site, shifting the equilibrium towards non-binding competent states in the native ensemble. Therefore, we provide a novel ensemble-based thermodynamic mechanism to explain catalytic defects caused by missense mutations that links large and transient conformational fluctuations and loss of catalytic efficiency and substrate/coenzyme affinity. In the context of this mechanism, we propose that allosteric ligands aimed at modulating these transient conformational fluctuations might correct catalytic defects in inherited metabolic diseases, representing a different approach to current small ligand therapies which target the low stability, but notcatalytic defects, of mutations.
Original languageEnglish
Pages (from-to)58604-58612
Number of pages9
JournalRSC Advances
Volume6
Issue number63
DOIs
Publication statusPublished - 13 Jun 2016

Fingerprint

NAD
Defects
Molecular dynamics
UDPglucose 4-Epimerase
Thermodynamics
Proteolysis
Ligands
Racemases and Epimerases
Proteins
Molecular modeling
X ray crystallography
Coenzymes
X ray scattering
Galactose
Conformations
Binding Sites
Degradation
Computer simulation
Substrates

Bibliographical note

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence

Cite this

@article{881b0a2b9f5f4a20b8403c416eeb90ab,
title = "Experimental and computational evidence on conformational fluctuations as a source of catalytic defects in genetic diseases",
abstract = "Theoretical and experimental evidences have shown that protein function, regulation and degradation are intrinsicallylinked to the dynamic and fluctuating nature of protein ensembles. However, the effect of missense mutations on catalytic performance are often interpreted from conformational analyses derived from X-ray crystallography, molecular dynamics and modeling, while effects on conformational fluctuations at the active site as the source of catalytic defects are rarely investigated. Here, we explore the role of conformational fluctuations in the catalytic efficiency of WT and three missense mutations in the UDP-Galactose 4´-epimerase (GALE) protein causing type III galactosemia. Using comprehensive molecular dynamics simulations and small angle X-ray scattering we correlate low NAD+ binding affinity in some mutants with an increased population of non-competent conformations for NAD+ binding. Proteolysis studies combined with thermodynamic calculations reveal that mutations affecting GALE catalytic performance favor larger conformational fluctuations at the N-terminal domain and NAD+ binding site, shifting the equilibrium towards non-binding competent states in the native ensemble. Therefore, we provide a novel ensemble-based thermodynamic mechanism to explain catalytic defects caused by missense mutations that links large and transient conformational fluctuations and loss of catalytic efficiency and substrate/coenzyme affinity. In the context of this mechanism, we propose that allosteric ligands aimed at modulating these transient conformational fluctuations might correct catalytic defects in inherited metabolic diseases, representing a different approach to current small ligand therapies which target the low stability, but notcatalytic defects, of mutations.",
author = "Fuchs, {Julian E.} and Munoz, {Ines G.} and David Timson and Pey, {Angel L.}",
note = "This article is licensed under a Creative Commons Attribution 3.0 Unported Licence",
year = "2016",
month = "6",
day = "13",
doi = "10.1039/C6RA05499D",
language = "English",
volume = "6",
pages = "58604--58612",
journal = "RSC Advances",
issn = "2046-2069",
number = "63",

}

Experimental and computational evidence on conformational fluctuations as a source of catalytic defects in genetic diseases. / Fuchs, Julian E.; Munoz, Ines G.; Timson, David; Pey, Angel L.

In: RSC Advances, Vol. 6, No. 63, 13.06.2016, p. 58604-58612.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Experimental and computational evidence on conformational fluctuations as a source of catalytic defects in genetic diseases

AU - Fuchs, Julian E.

AU - Munoz, Ines G.

AU - Timson, David

AU - Pey, Angel L.

N1 - This article is licensed under a Creative Commons Attribution 3.0 Unported Licence

PY - 2016/6/13

Y1 - 2016/6/13

N2 - Theoretical and experimental evidences have shown that protein function, regulation and degradation are intrinsicallylinked to the dynamic and fluctuating nature of protein ensembles. However, the effect of missense mutations on catalytic performance are often interpreted from conformational analyses derived from X-ray crystallography, molecular dynamics and modeling, while effects on conformational fluctuations at the active site as the source of catalytic defects are rarely investigated. Here, we explore the role of conformational fluctuations in the catalytic efficiency of WT and three missense mutations in the UDP-Galactose 4´-epimerase (GALE) protein causing type III galactosemia. Using comprehensive molecular dynamics simulations and small angle X-ray scattering we correlate low NAD+ binding affinity in some mutants with an increased population of non-competent conformations for NAD+ binding. Proteolysis studies combined with thermodynamic calculations reveal that mutations affecting GALE catalytic performance favor larger conformational fluctuations at the N-terminal domain and NAD+ binding site, shifting the equilibrium towards non-binding competent states in the native ensemble. Therefore, we provide a novel ensemble-based thermodynamic mechanism to explain catalytic defects caused by missense mutations that links large and transient conformational fluctuations and loss of catalytic efficiency and substrate/coenzyme affinity. In the context of this mechanism, we propose that allosteric ligands aimed at modulating these transient conformational fluctuations might correct catalytic defects in inherited metabolic diseases, representing a different approach to current small ligand therapies which target the low stability, but notcatalytic defects, of mutations.

AB - Theoretical and experimental evidences have shown that protein function, regulation and degradation are intrinsicallylinked to the dynamic and fluctuating nature of protein ensembles. However, the effect of missense mutations on catalytic performance are often interpreted from conformational analyses derived from X-ray crystallography, molecular dynamics and modeling, while effects on conformational fluctuations at the active site as the source of catalytic defects are rarely investigated. Here, we explore the role of conformational fluctuations in the catalytic efficiency of WT and three missense mutations in the UDP-Galactose 4´-epimerase (GALE) protein causing type III galactosemia. Using comprehensive molecular dynamics simulations and small angle X-ray scattering we correlate low NAD+ binding affinity in some mutants with an increased population of non-competent conformations for NAD+ binding. Proteolysis studies combined with thermodynamic calculations reveal that mutations affecting GALE catalytic performance favor larger conformational fluctuations at the N-terminal domain and NAD+ binding site, shifting the equilibrium towards non-binding competent states in the native ensemble. Therefore, we provide a novel ensemble-based thermodynamic mechanism to explain catalytic defects caused by missense mutations that links large and transient conformational fluctuations and loss of catalytic efficiency and substrate/coenzyme affinity. In the context of this mechanism, we propose that allosteric ligands aimed at modulating these transient conformational fluctuations might correct catalytic defects in inherited metabolic diseases, representing a different approach to current small ligand therapies which target the low stability, but notcatalytic defects, of mutations.

U2 - 10.1039/C6RA05499D

DO - 10.1039/C6RA05499D

M3 - Article

VL - 6

SP - 58604

EP - 58612

JO - RSC Advances

JF - RSC Advances

SN - 2046-2069

IS - 63

ER -